116 related articles for article (PubMed ID: 6359740)
1. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
Ratzmann KP; Jutzi E; Albrecht G
Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
[TBL] [Abstract][Full Text] [Related]
2. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
Petkova M; Khristov V; Tsanev A
Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
[TBL] [Abstract][Full Text] [Related]
3. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
Christiansen JS; Svendsen PA; Deckert T
Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
[TBL] [Abstract][Full Text] [Related]
4. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
[TBL] [Abstract][Full Text] [Related]
5. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
[TBL] [Abstract][Full Text] [Related]
6. Preprogrammed insulin infusion with a portable pump system.
Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
[TBL] [Abstract][Full Text] [Related]
7. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
[TBL] [Abstract][Full Text] [Related]
8. Diurnal pattern of insulin requirements in insulin-dependent diabetics.
Mathiesen ER; Rubin P; Sandahl Christiansen J; Aaby Svendsen P; Lauritzen T; Deckert T
Scand J Clin Lab Invest; 1982 Feb; 42(1):63-8. PubMed ID: 6753093
[TBL] [Abstract][Full Text] [Related]
9. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
[TBL] [Abstract][Full Text] [Related]
11. Validation of closed-loop subcutaneous insulin infusion algorithm--application of subcutaneous insulin absorption kinetics.
Asakawa N; Saito Y; Yamasaki Y; Kawamori R; Shichiri M
Diabetes Res; 1987 Aug; 5(4):193-8. PubMed ID: 3311559
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
Stavljenić A; Granić M; Topić B; Skrabalo Z
Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
[TBL] [Abstract][Full Text] [Related]
13. [Use of an artificial B-cell in clinic and experimental medicine].
Fischer U; Bruns W; Jutzi E; Ratzmann KP; Abel P; Bombor H; Salzsieder E; Freyse EJ
Z Gesamte Inn Med; 1981 Jan; 36(1):19-26. PubMed ID: 7013292
[TBL] [Abstract][Full Text] [Related]
14. Glucose controlled insulin infusion system (Biostator) application during surgery for a presumed pancreatic microinsulinoma.
Massi-Benedetti M; Noy G; Johnston ID; Worth R; Alberti KG
Diabete Metab; 1981 Mar; 7(1):41-4. PubMed ID: 6263727
[TBL] [Abstract][Full Text] [Related]
15. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
[TBL] [Abstract][Full Text] [Related]
16. Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus.
Chiasson JL; el Achkar GG; Ducros F; Bourque J; Maheux P
Clin Invest Med; 1997 Jun; 20(3):140-51. PubMed ID: 9189645
[TBL] [Abstract][Full Text] [Related]
17. Developmental and application of insulin infusion profiles for therapy of type-I diabetics with portable insulin infusion systems.
Schulz G; Strack T; Beyer J; Krause U; Cordes U; Weber T; Nagel J; Beutelspacher F
Life Support Syst; 1984; 2(3):189-200. PubMed ID: 6503348
[TBL] [Abstract][Full Text] [Related]
18. Assessment of insulin needs in insulin-dependent diabetics and healthy volunteers under fasting conditions.
Beyer J; Krause U; Dobronz A; Fuchs B; Delver JR; Wagner R
Horm Metab Res Suppl; 1990; 24():71-7. PubMed ID: 2272630
[TBL] [Abstract][Full Text] [Related]
19. [Feasibility and reproductibility of a euglycemic hyperinsulinic glucose clamp technic].
Gin H; Brunel PG; Brottier E; Aubertin J; Drouin P; Debry G
Diabete Metab; 1984 Jan; 10(1):36-8. PubMed ID: 6373424
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
